Helmer Scientific expands GX Solutions refrigerator line
Aug. 23, 2019–Helmer Scientific announced the launch of its upright laboratory, pharmacy, and blood bank GX Solutions refrigerators, with models ranging from 13 to 56 cubic feet.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
South Bend Medical Foundation sells diagnostic lab to LabCorp
Aug. 2, 2019—South Bend Medical Foundation announced it will sell its diagnostic clinical laboratory testing assets to LabCorp. SBMF will reinvest the proceeds from the sale into the organization to further enhance and modernize facilities and procedures, ensure the ability to fund retiree pensions, and focus on its core business of pathology and blood banking services.
FDA clears new indications for existing Lyme disease tests
Aug. 1, 2019—The U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease. The tests cleared involve a new testing paradigm in which two enzyme immunoassays are run concurrently or sequentially, rather than the current two-step process in which a Western blot must be run after the initial EIA test.
Exact Sciences to buy Genomic Health for $2.8 billion
July 29, 2019–Exact Sciences and Genomic Health announced today that the companies have entered into a definitive agreement in which Exact Sciences will combine with Genomic Health for $2.8 billion. The two companies will create a worldwide cancer diagnostics company, joining its two brands Cologuard and Oncotype DX, respectively. The combined company expects to generate revenue of approximately $1.6 billion and gross profit of approximately $1.2 billion in 2020.
FDA clears iCubate iC-GN Assay
July 18, 2019—The U.S. Food and Drug Administration has cleared iCubate’s iC-GN Assay for the detection and identification of Gram-negative bacteria that are associated with bloodstream infection and subsequent sepsis.
FDA approves Alinity s blood, plasma screening system
July 15, 2019—Abbott announced FDA approval for its blood and plasma screening instrument, the Alinity s System.
Bio-Rad ddPCR microsatelIite instability assay
July 10, 2019–Bio-Rad’s droplet digital PCR microsatellite instability research use only assay is available for early access customers.
Afinion HbA1c Dx assay now available on Afinion 2
June 21, 2019— Abbott announced that its Afinion HbA1c Dx assay, the first rapid point-of-care test cleared
OGT releases SureSeq NGS library prep kit
June 19, 2019– Oxford Gene Technology has expanded its SureSeq portfolio with the SureSeq NGS Library Preparation Kit, a library preparation solution for hybridization-based target capture in next-generation sequencing.
Advanced Instruments’ osmometer peer group program
June 17, 2019—Advanced Instruments launched its Web-based Advanced QC Peer Group program, which allows laboratories to compare their osmometer serum and urine QC with their peers’ data on a real-time and monthly basis. The program is designed to help laboratories troubleshoot issues by providing instant and monthly reports to evaluate internal and external performance in real time. It also aims to give labs increased assurance in proficiency survey and patient results. “We are pleased to deliver a program that helps